Testing a non-invasive ear device for autism spectrum disorder
Tests a non-invasive ear-based nerve stimulation device in people with autism.
Plain-language title generated from the registry record
Registry title: Non-invasive Auricular Fiber Vagus Nerve Stimulation (afVNS) for Treatment of Autism Spectrum Disorder
Key facts
- Where
- Tai Po, Hong KongSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 7 and 26 years old?
Source: NCT06473623, who can take part
Where in Hong Kong
- Hong Kong Science ParkTai Po, Hong KongTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Neuropix
- Trial code
- NCT06473623
- Record updated
- 8 January 2026
- Original description
Non-invasive vagus nerve stimulation for the symptomatic improvements in Autism Spectrum DisorderRead full original descriptionShow less
Non-invasive Auricular Fiber Vagus Nerve Stimulation (afVNS) for Treatment of Autism Spectrum Disorder: An Open-Label Trial
Non-invasive vagus nerve stimulation for the symptomatic improvements in Autism Spectrum Disorder
Inclusion: Written informed consent; Age: between 7 and 26 years; Participants and parent/ guardian must have proficiency in English; Diagnosis of ASD as defined by ADOS-2 or DSM-5 criteria.
Exclusion: Active medical implants (cochlear, VNS or pacemakers); Severe psychiatric disorders (e.g. bipolar, major depressive disorder); Severe neurological disorders (e.g. stroke, epilepsy); History of head trauma (surgery or tumor); Auricular skin disease that compromises placement of electrodes; Bradyarrhythmia; Cerebral shunts; Pregnancy.